| Measles and Rubella Diagnostic and Classification Challenges in Near-and Post-Elimination Countries TD Filardo, SN Crooke, B Bankamp, K Raines, AD Mathis, TM Lanzieri, ... Vaccines 12 (6), 697, 2024 | | 2024 |
| Identifying a level of neutralizing antibody that correlates with protection from clinical mumps disease during a 2017 mumps outbreak among military service members SB Sowers, NS Clemmons, S Mercader, L Nielsen, H Colley, NN Jordan, ... Open Forum Infectious Diseases, ofae329, 2024 | | 2024 |
| Breakthrough Measles among Vaccinated Adults Born during the Post-Soviet Transition Period in Mongolia JE Hagan, SN Crooke, N Gunregjav, SB Sowers, S Mercader, ... Vaccines 12 (6), 695, 2024 | | 2024 |
| Measles IgG Avidity Assay S Mercader, S Crooke Measles and Related Morbilliviruses: Methods and Protocols, 247-264, 2024 | | 2024 |
| A measles and rubella vaccine microneedle patch in The Gambia: a phase 1/2, double-blind, double-dummy, randomised, active-controlled, age de-escalation trial I Adigweme, M Yisa, M Ooko, E Akpalu, A Bruce, S Donkor, LB Jarju, ... The Lancet 403 (10439), 1879-1892, 2024 | 3 | 2024 |
| Measles—United States, January 1, 2020–March 28, 2024 AD Mathis MMWR. Morbidity and Mortality Weekly Report 73, 2024 | 5 | 2024 |
| Long-term Neutralizing Antibody Levels Against Measles and Rubella Viruses Among Adults With 3 Doses of Measles-Mumps-Rubella Vaccine OD Alonge, M Marin, CJ Hickman, SB Sowers, M Chen, L Hao, ... Open Forum Infectious Diseases 11 (1), ofad700, 2024 | 1 | 2024 |
| 1148. Long-term Persistence of Measles and Rubella Virus Neutralizing Antibody Levels among Adults with Three Doses of Measles-Mumps-Rubella Vaccine O Alonge, M Marin, CJ Hickman, SB Sowers, M Chen, L Hao, J Icenogle, ... Open Forum Infectious Diseases 10 (Supplement_2), ofad500. 989, 2023 | | 2023 |
| Measles and Rubella Viruses SN Crooke, MM Coughlin, LM Perelygina Manual of Clinical Microbiology 13, 1741-1761, 2023 | | 2023 |
| We Must Maintain Measles Elimination in the United States: Measles Clinical Presentation, Diagnosis, and Prevention A Mathis, D Filardo, S Crooke | | 2023 |
| Preparation and Biological Properties of Oligonucleotide-Functionalized Virus-like Particles R Hincapie, S Bhattacharya, P Keshavarz-Joud, AP Chapman, ... Biomacromolecules 24 (6), 2766-2776, 2023 | 1 | 2023 |
| Notes from the field: measles outbreak—central Ohio, 2022–2023 EC Tiller MMWR. Morbidity and Mortality Weekly Report 72, 2023 | 5 | 2023 |
| Performance characteristics of six immunoglobulin M enzyme-linked immunosorbent assays used for laboratory confirmation of measles SB Sowers, K Anthony, S Mercader, H Colley, SN Crooke, PA Rota, ... Journal of Clinical Microbiology 60 (12), e01227-22, 2022 | 2 | 2022 |
| Performance Characteristics of Six Immunoglobulin M (IgM) ELISA Assays Used for Laboratory Confirmation of Measles SB Sowers, K Anthony, S Mercader, H Colley, SN Crooke, PA Rota, ... medRxiv, 2022.09. 02.22279538, 2022 | | 2022 |
| Measles, mumps, rubella vaccine (PRIORIX): recommendations of the Advisory Committee on Immunization Practices—United States, 2022 E Krow-Lucal MMWR. Morbidity and Mortality Weekly Report 71, 2022 | 7 | 2022 |
| Public health actions to control measles among Afghan evacuees during operation allies welcome—United States, September–November 2021 NB Masters MMWR. Morbidity and mortality weekly report 71, 2022 | 8 | 2022 |
| Inflammasome activity in response to influenza vaccination is maintained in monocyte-derived peripheral blood macrophages in older adults S Crooke, K Goergen, IG Ovsyannikova, R Kennedy Frontiers in Aging, 37, 2021 | 1 | 2021 |
| Single-point mutations in Qβ virus-like particles change binding to cells ML Martino, SN Crooke, M Manchester, MG Finn Biomacromolecules 22 (8), 3332-3341, 2021 | 15 | 2021 |
| Identification of naturally processed Zika virus peptides by mass spectrometry and validation of memory T cell recall responses in Zika convalescent subjects SN Crooke, IG Ovsyannikova, RB Kennedy, GA Poland PloS one 16 (6), e0252198, 2021 | 10 | 2021 |
| Durability of humoral immune responses to rubella following MMR vaccination SN Crooke, MM Riggenbach, IG Ovsyannikova, ND Warner, MH Chen, ... Vaccine 38 (51), 8185-8193, 2020 | 12 | 2020 |
Rick KennedyProfessor of Medicine, Mayo Clinic在 mayo.edu 的电子邮件经过验证
